Fingerprint
Dive into the research topics of 'Continuation of gefitinib plus chemotherapy prolongs progressionfree survival in advanced non-small cell lung cancer patients who get acquired resistance to gefitinib without T790M mutations'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically